Quick Takeaways
- David P. Meeker has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $32,360,589.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of David P. Meeker
- Location
- Boston, MA
- Summary
- The estimated net worth of David P. Meeker is at least $32,360,589 dollars as of 18 Mar 2026. David P. Meeker is the President and CEO, Director of RHYTHM PHARMACEUTICALS, INC. and owns shares of RHYTHM PHARMACEUTICALS, INC. (RYTM) stock worth about $29.7M. David P. Meeker is the Director of Pharvaris N.V. and owns shares of Pharvaris N.V. (PHVS) stock worth about $1.63M. David P. Meeker is the Director of Trevi Therapeutics, Inc. and owns shares of Trevi Therapeutics, Inc. (TRVI) stock worth about $1.03M.
- Signature
- /s/ Marnus Nel, Attorney-in-Fact for David Meeker
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow David P. Meeker and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: RHYTHM PHARMACEUTICALS, INC. ($29,698,128).
- Past-year value change for that position: -$2,837,333.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of David P. Meeker
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| RYTM | RHYTHM PHARMACEUTICALS, INC. | President and CEO, Director | $29,698,128 | -$2,837,333 | -8.7% | 11 Feb 2026 |
| PHVS | Pharvaris N.V. | Director | $1,629,175 | 18 Mar 2026 | ||
| TRVI | Trevi Therapeutics, Inc. | Director | $1,033,286 | 11 Jun 2025 |
Insider Transactions Reported by David P. Meeker:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.